This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.
| Name | Shares | Options |
|---|---|---|
| Beacon Co By Purdue Pharma L.P. | 5,416,565 | 0 |
| Rosebay Medical Co L.P. By Purdue Pharma L.P. | 5,416,565 | 0 |
| Perkins Adelene Q | 1,175,291 | 0 |
| BLOCH LAWRENCE E | 580,944 | 335,000 |
| EVNIN ANTHONY B By Funds and LLC | 294,071 | 0 |
| VENUTI MICHAEL C | 50,000 | 30,000 |
| Peluso Stephane | 37,052 | 0 |
| Palombella Vito J. | 868 | 0 |
| KANGO SUJAY | 599 | 90,000 |
| Lynch Thomas J. Jr. | 0 | 15,000 |
| Holtzman Steven H | 0 | 0 |
| Palombella Vito J. 401(k) | 0 | 0 |
| EVNIN ANTHONY B | 0 | 30,000 |
| PROSPECT MANAGEMENT CO LLC By Prospect Venture Partners II, L.P. | 0 | 0 |
| Hamermesh Joshua | 0 | 14,940 |
| SELBY NORMAN C | 0 | 10,000 |
| Kutok Jeffery | 0 | 450,000 |
| Ilaria Robert Jr. | 0 | 300,000 |
| Berkowitz Jeffrey | 0 | 30,000 |
| Roth David By 401(k) | 0 | 0 |
| LEVINE ARNOLD J | 0 | 6,000 |
| BVF PARTNERS L P/IL | 0 | 0 |
| Tasker Seth A | 0 | 225,000 |
| EVNIN ANTHONY B By Funds | 0 | 0 |
| ADAMS JULIAN | 0 | 80,000 |
| Kutok Jeffery By 401(k) | 0 | 0 |
| Tasker Seth A By 401(k) | 0 | 0 |
| Lindblom Christopher M | 0 | 40,000 |
| Tucker Winselow S. Jr. | 0 | 22,410 |
| BEIER DAVID W | 0 | 30,000 |
| LAMPERT MARK N | 0 | 0 |
| Quirk Gerald E | 0 | 40,000 |
| Agresta Samuel | 0 | 30,000 |
| SMITH IAN F | 0 | 4,000 |
| Rosebay Medical Co L.P. | 0 | 0 |
| PROSPECT MANAGEMENT CO LLC By Prospect Venture Partners, L.P. | 0 | 0 |
| Bertrand William C JR | 0 | 200,000 |
| Babler Martin | 0 | 15,000 |
| Lee Patrick Pak-Tin | 0 | 6,000 |
| 0 | 0 | |
| GAYNOR RICHARD | 0 | 30,000 |
| Kauffman Michael | 0 | 30,000 |
| LANDER ERIC S | 0 | 15,000 |
| Beacon Co | 0 | 0 |
| SCHWARTZ BRIAN | 0 | 60,000 |
| Baselga Jose | 0 | 40,000 |
| Fyfe Gwen A. | 0 | 15,000 |
| Santabarbara Pedro | 0 | 16,600 |
| Lam Winston K.C. | 0 | 200,000 |
| Roth David | 0 | 85,000 |
While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price
| Name | Shares | Price | Date |
|---|---|---|---|
| Perkins Adelene Q | 410,196 | 0.07 | 2023 Sep 12 |
Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.
| Name | Shares | Price | Date |
|---|